Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 March 2019 | Story Xolisa Mnuwka | Photo Charl Devenish
Stagedoor Finals
Houses Vergeet-My-Nie and NJ van der Merwe won over the judges at the 2019 Stagedoor finals.

‘Vergeet van der Merwe’, a hybrid of female residences Vergeet-my-Nie and NJ van der Merwe, are the 2019 Stagedoor competition’s overall winners. The dynamic girl duo showed up and showed off during the 2019 Stagedoor finals in the Kopanong Auditorium on the UFS Bloemfontein Campus over the weekend.

The girls enthused the audience with a soul-filled sing-off and a relatable theatrical performance, which earned them both the audience’s and the judge’s best votes. Teams Welwitschia and Imperium (Welperium), and Outeniqua and Soetdoring (Outdoring), walked away with the second and third positions respectively, as each of the residences were recognised for team excellence and spirit when it came to creativity and overall acting in each of their performances.

The UFS Stagedoor competition is an annual event that employs first-years to take cognisance of the day-to-day societal issues and pressures that university students are faced with. In 2019, the event was for the first time entirely organised and ran by students for students.

The competition has over the years become a major highlight on UFS students’ arts and culture calendar and continues to be a platform of expression for residence and off-campus first-year students. Stagedoor performances are traditionally themed to tackle modern-day issues such as infrastructure and economic inequality, land reform, and education. However, this year’s competition engaged students in telling their stories without any restrictions, and still being able to effectively examine the pressures that come with varsity life, and many other issues that face South Africa, but more specifically the youth. The 2019 Stagedoor event was successfully coordinated and structured by UFS Bloemfontein Campus SRC: Arts and Culture, Patrick Chirilele, with help from Residence Committee (RC) Culture members.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept